ArticleScientific reports2025
Redox properties of quercetin iron Ii complex with enhanced antioxidant and antiviral activities.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Green synthesis of TiORSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Quercetin is a naturally occurring flavonoid widely recognized for its potent antioxidant, anti-inflammatory, and anticancer effects. However, its clinical application is limited by low water solubility and poor bioavailability. In this study, the complexation of quercetin with iron (II) ions was systematically investigated through electrochemical, spectroscopic, biological, and computational techniques to improve its physicochemical and pharmacological performance. Cyclic voltammetry revealed that quercetin undergoes irreversible oxidation due to semiquinone and para-quinonemethide formation, while Fe(II) exhibited quasi-reversible redox behavior, which became less reversible upon complexation, suggesting altered electron transfer kinetics. The stability constant (log βMX = 3.29) and the negative Gibbs free energy (ΔG = - 19.07 kJ/mol) confirmed spontaneous and thermodynamically favorable complex formation. UV-Vis spectroscopy showed significant bathochromic shifts (Δλ = 66 nm), and the continuous variation method established a 1:1 metal-to-ligand stoichiometry. ¹H NMR spectroscopy and X-ray diffraction patterns further confirmed the coordination sites and structural modifications upon metal binding. The Fe(II)-quercetin complex demonstrated superior antioxidant capacity in DPPH radical scavenging assays, with an IC₅₀ of 21.86 µg/mL compared to 23.47 µg/mL for free quercetin, confirming enhanced radical scavenging activity upon complexation. Cytotoxicity assays on HepG2 and MCF-7 cancer cell lines revealed enhanced bioactivity of the complex, with IC₅₀ values of 26.80 and 18.60 µM, respectively. Antifungal testing showed moderate inhibition against Candida albicans. Molecular docking simulations using the SARS-CoV-2 spike protein (PDB: 7JWY) indicated stronger binding affinity for the complex (- 5.42 kcal/mol) than quercetin alone, suggesting potential antiviral efficacy. Additionally, DFT calculations revealed increased softness and electrophilicity of the complex, supporting its enhanced reactivity. Collectively, these findings position the Fe(II)-quercetin complex as a promising multifunctional agent with potential applications in antioxidant therapy, cancer treatment, and antiviral drug development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.